From New York’s Life Science Disruptors: The Photos:

Samuel Waksal, former CEO and chairman of Kadmon Holdings

Samuel Waksal, former CEO and chairman of Kadmon Holdings—

Sam Waksal, ImClone, Kadmon, New York Life Science Disruptors, keith spiro photography

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Video
Fish & Richardson: Patent Law in Regards to AI and Machine Learning
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Fish & Richardson

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!